Skip to content

Public FDA record

Z-1377-04: Abbott Clinical Chemistry AEROSET/ ARCHITECT c8000 Creatinine. List No. 7D64-20

Recall record Z-1377-04 for Abbott Laboratories Diagnostic Div. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1377-04
Company in FDA record
Abbott Laboratories Diagnostic Div
FDA classification date
Aug 17, 2004
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Precipitate formed in product.

Source facts

Action
Firm sent recall letters requesting destruction of kits in the field on July 27, 2004.
Initiated
2004-07-27
Root cause
Other
Terminated
2012-05-02
Distribution
Nationwide and to Mexico, Columbia, Ecuador, Brazil, Puerto Rico, Domincan Republic, Canada, Germany, Singapore, Hong Kong, India, Thailand, Australia, New Zealand, Bahamas.
Recall number
Z-1377-04
Recall status
Terminated
CDRH record ID
34342
FDA classified
2004-08-17
Recall event number
29684

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗